Entyvio 300 MG vials

Ended Awarded Last action

Contract number
SPE2DR26FLTN9
Awardee
Awarding agency
Obligated
$49,663

Award facts

Contract value 100% obligated
$49,662.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $49,662.50 delivery order to DMS Pharmaceutical Group Inc. on January 28, 2026, for 4,570,651,550 units of Entyvio 300 mg vials, with an ultimate completion date of January 29, 2026.

The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499,999,999 ceiling. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order carries firm fixed-price pricing with no set-aside designation.

Quick answers

Who was awarded contract SPE2DR26FLTN9?

SPE2DR26FLTN9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.

How much is contract SPE2DR26FLTN9 worth?

The government has obligated $49,663 on SPE2DR26FLTN9.

Is contract SPE2DR26FLTN9 an order under another contract?

Yes. SPE2DR26FLTN9 is a delivery order under SPE2DR25D9766, an indefinite delivery contract.

Was contract SPE2DR26FLTN9 competed?

The extent of competition for SPE2DR26FLTN9 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login